Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era

Harmke J. Groot, Sjoukje Lubberts, Ronald de Wit, Johannes A. Witjes, Jan Martijn Kerst, Igle J. de Jong, Gerard Groenewegen, Alfons J. M. van den Eertwegh, Philip M. Poortmans, Heinz-Josef Klumpen, Hetty A. van den Berg, Tineke J. Smilde, Ben G. L. Vanneste, Maureen J. Aarts, Luca Incrocci, Alfons C. M. van den Bergh, Katarzyna Jozwiak, Alexandra W. van den Belt-Dusebout, Simon Horenblas, Jourik A. GietemaFlora E. van Leeuwen, Michael Schaapveld*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2504-2513
Number of pages10
JournalJournal of Clinical Oncology
Volume36
Issue number24
DOIs
Publication statusPublished - 20 Aug 2018

Keywords

  • LONG-TERM SURVIVORS
  • CHILDHOOD-CANCER
  • 2ND CANCERS
  • MOLECULAR-MECHANISMS
  • CHEMOTHERAPY
  • RADIOTHERAPY
  • CISPLATIN
  • MANAGEMENT
  • MORTALITY
  • NEOPLASMS
  • SURVIVORS

Cite this